GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Total Debt/Equity History
[Consolidated]
Mar2024 | |
---|---|
Total Debt/Equity(x) | 0.60 |
What is the latest Total Debt/Equity ratio of GUFIC BIOSCIENCES ?
Year | Total Debt/Equity |
---|---|
Mar2024 | 0.60 |
How is Total Debt/Equity of GUFIC BIOSCIENCES Trending?
Years | Total Debt/Equity | % Change | |
---|---|---|---|
Mar2024 | 0.6 | - |
Other Financial Ratios of GUFIC BIOSCIENCES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Total Debt/Equity ratio of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,709.6 Cr | -2.8% | -2.1% | -11.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,718.0 Cr | 1% | -0.9% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,282.0 Cr | -1.6% | -1.8% | 17.9% | Stock Analytics | |
CIPLA | ₹125,351.0 Cr | -1.8% | 3.7% | -6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,267.0 Cr | 0.7% | 2.4% | 3.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,952.0 Cr | -0.6% | 4.5% | -6.5% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | -2.8% |
-2.1% |
-11.6% |
SENSEX | 1.2% |
0.7% |
-1.5% |
You may also like the below Video Courses